Hedda Haugen Cange

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer

Maria Gebre‐Medhin, Eva Brun, Per Engström et al. · Journal of Clinical Oncology · 2020 · 177 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour

Ellen Wolff, K. Miriam Elfström, Hedda Haugen Cange et al. · Vaccine · 2018 · 44 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)

Georgios Tsakonas, Lena Specht, Claus Andrup Kristensen et al. · Cancers · 2020 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16

A national study of health‐related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma

Malin Berg, Ali Adnan, Anders Högmo et al. · Head & Neck · 2021 · 11 citations

Medicine, Oncology, Otolaryngology +10